Phase III Study of Idelalisib /Rituximab for Relapsed Chronic Lymphocytic Leukemia

Dr. Jeff Sharman analysis of a phase 3 study of idelalisib plus rituximab for relapsed chronic lymphocytic leukemia: efficacy analysis in patient subpopulations with Del(17p) and other adverse prognos... Author: feeds Added: 04/15/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts